 "Panel recommends portal to monitor online sale of drugs")
A sub-committee constituted to examine issues relating to the online sale of drug has recommended the creation of a national portal to act as a platform for transacting and monitoring online sale of drugs and evolving a mechanism to register e-pharmacies.
Minister of State for Health Faggan Singh Kulaste, in written reply to a question in the Rajya Sabha today, said that the committee has also recommended exclusion of certain drugs like narcotic drugs and tranquilisers, which are prone to being "abused or misused", from online sale.
"A sub-committee had been constituted by the Drugs Consultative Committee (DCC) to examine issues relating to online sale of drugs. The sub-committee has submitted its report to the DCC.
"The sub-committee has recommended creation of a national portal to act as the nodal platform for transacting and monitoring online sale of drugs and necessity of evolving a mechanism to register e-pharmacies," the minister said.
The committee has also recommended geographical restrictions for operation of e-pharmacies and said that existing licencees involved in retail sale of drugs could also register on the national portal for carrying out online sale of drugs.
"Certain categories of drugs viz. The narcotic and psychotropic drugs, tranquilisers, habit forming drugs and Schedule X drugs that are prone to being abused or misused be excluded from sale through e-pharmacies," Kulaste said.
He said that all matters relating to sale of drugs including through online will continue to be regulated in accordance with the provisions of the Drugs and Cosmetics Rules, 1945 as amended from time to time.
Minister of State for Health Faggan Singh Kulaste, in written reply to a question in the Rajya Sabha today, said that the committee has also recommended exclusion of certain drugs like narcotic drugs and tranquilisers, which are prone to being "abused or misused", from online sale.
"A sub-committee had been constituted by the Drugs Consultative Committee (DCC) to examine issues relating to online sale of drugs. The sub-committee has submitted its report to the DCC.
"The sub-committee has recommended creation of a national portal to act as the nodal platform for transacting and monitoring online sale of drugs and necessity of evolving a mechanism to register e-pharmacies," the minister said.
The committee has also recommended geographical restrictions for operation of e-pharmacies and said that existing licencees involved in retail sale of drugs could also register on the national portal for carrying out online sale of drugs.
"Certain categories of drugs viz. The narcotic and psychotropic drugs, tranquilisers, habit forming drugs and Schedule X drugs that are prone to being abused or misused be excluded from sale through e-pharmacies," Kulaste said.
He said that all matters relating to sale of drugs including through online will continue to be regulated in accordance with the provisions of the Drugs and Cosmetics Rules, 1945 as amended from time to time.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%